# Dupilumab for Severe Asthma in a Real Life Setting

> **NCT04022447** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 86 (actual)

## Conditions studied

- Severe Asthma

## Interventions

- **DRUG:** Dupilumab

## Key facts

- **NCT ID:** NCT04022447
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-10
- **Primary completion:** 2019-04-02
- **Final completion:** 2019-04-02
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2019-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04022447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04022447, "Dupilumab for Severe Asthma in a Real Life Setting". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04022447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*